Clinical Trial Update: 18F-AV-1451 PET Imaging in TBI [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the PET imaging tracer 18F-AV-1451 (flortaucipir) for traumatic brain injury has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• 18F-AV-1451 (flortaucipir) (flortaucipir)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Traumatic Brain Injury | Phase 1 | Status: WITHDRAWN